126 related articles for article (PubMed ID: 6685826)
21. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
Kilpatrick GJ; Jenner P; Marsden CD
J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
[TBL] [Abstract][Full Text] [Related]
22. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
24. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
Mjörndal T; Persson SA
Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of 3H-cis-flupenthixol binding in rat striatum.
Murrin LC
Life Sci; 1983 Nov; 33(22):2179-86. PubMed ID: 6645796
[TBL] [Abstract][Full Text] [Related]
26. Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.
Hyttel J
Psychopharmacology (Berl); 1980 Jan; 67(1):107-9. PubMed ID: 6768074
[TBL] [Abstract][Full Text] [Related]
27. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes.
Cross AJ; Owen F
Eur J Pharmacol; 1980 Aug; 65(4):341-7. PubMed ID: 7408943
[TBL] [Abstract][Full Text] [Related]
29. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
Weller ME; Rose S; Jenner P; Marsden CD
Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
[TBL] [Abstract][Full Text] [Related]
30. A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine.
Davis AS; Jenner P; Marsden CD
Br J Pharmacol; 1986 Jan; 87(1):129-37. PubMed ID: 3955297
[TBL] [Abstract][Full Text] [Related]
31. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
32. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
Lau YS; Runice C
Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
[TBL] [Abstract][Full Text] [Related]
33. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment.
Honkanen A; Piepponen TP; Ahtee L
Neurosci Lett; 1994 Oct; 180(2):119-22. PubMed ID: 7700562
[TBL] [Abstract][Full Text] [Related]
34. Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans-(-)-5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido less than 4,5-g greater than quinolin-2-amine dihydrochloride, a potent and stereospecific dopamine (D2) agonist.
Bymaster FP; Reid LR; Nichols CL; Kornfeld EC; Wong DT
Life Sci; 1986 Jan; 38(4):317-22. PubMed ID: 3753738
[TBL] [Abstract][Full Text] [Related]
35. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
36. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
[No Abstract] [Full Text] [Related]
37. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.
Hyttel J
Life Sci; 1978 Aug; 23(6):551-5. PubMed ID: 29194
[No Abstract] [Full Text] [Related]
38. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats.
Rowlett JK; Mattingly BA; Bardo MT
Neuropharmacology; 1991 Feb; 30(2):191-7. PubMed ID: 1903190
[TBL] [Abstract][Full Text] [Related]
39. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
40. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
Scavone C; De Lucia R; Bernardi MM; Aizenstein ML
Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
